AUGS Webinar (Industry Edition): Medtronic InterStim™ Therapy: Remarkable Legacy, Bright Futures; Fellows Horizion (On-Demand)-Medtronic Video

Video Transcription

Video Summary

In this video, Dr. Fishburne, a urogynecologist, discusses sacral neuromodulation as a treatment option for overactive bladder and fecal incontinence. He thanks AUGS and Medtronic for their support in his career and the sponsorship of the meeting. Dr. Fishburne highlights the prevalence of these conditions and the impact they have on patients' lives. He discusses the treatment guidelines and society recommendations for sacral neuromodulation, emphasizing the importance of thorough evaluation and non-invasive treatment options before considering advanced therapies. He explains the two evaluation options available, basic evaluation and advanced evaluation, and shares his experience with basic evaluation being done in the office. He discusses the indications, contraindications, and mechanism of action of sacral neuromodulation. Dr. Fishburne reviews the long-term clinical data for overactive bladder, non-obstructive urinary retention, and fecal incontinence, showing high success rates. He explains the choices between the Interstim 2 recharge-free system and the Interstim Micro rechargeable system, discussing their features and benefits. Finally, he talks about patient management and programming basics, emphasizing the importance of ongoing care and addressing other factors that may impact treatment outcomes. The video concludes with a QR code for additional online learning resources.

Keywords

sacral neuromodulation

overactive bladder

fecal incontinence

treatment option

urogynecologist

prevalence

evaluation options

mechanism of action

Interstim system